AMERICAN INTERNATIONAL GROUP, INC. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$1,898,449
-13.9%
119,625
+2.4%
0.01%
-7.7%
Q2 2023$2,204,431
+454.0%
116,822
+12.7%
0.01%
+333.3%
Q1 2023$397,916
-21.0%
103,624
+2.0%
0.00%
-25.0%
Q4 2022$503,748
+3.4%
101,562
-0.4%
0.00%0.0%
Q3 2022$487,000
+7.7%
101,932
+1.4%
0.00%
+33.3%
Q2 2022$452,000
-11.0%
100,491
-5.8%
0.00%0.0%
Q1 2022$508,000
-34.9%
106,706
+1.5%
0.00%
-25.0%
Q4 2021$780,000
+27.0%
105,116
-2.9%
0.00%
+33.3%
Q3 2021$614,000
-15.0%
108,261
-1.1%
0.00%
+50.0%
Q2 2021$722,000
-20.3%
109,485
-2.1%
0.00%
-33.3%
Q1 2021$906,000
+30.7%
111,795
+4.1%
0.00%0.0%
Q4 2020$693,000
+87.3%
107,387
+4.5%
0.00%
+50.0%
Q3 2020$370,000
-23.4%
102,739
-2.2%
0.00%0.0%
Q2 2020$483,000
+41.6%
105,075
+5.0%
0.00%0.0%
Q1 2020$341,000
-26.5%
100,026
+10.1%
0.00%0.0%
Q4 2019$464,000
+109.0%
90,816
-0.8%
0.00%
+100.0%
Q3 2019$222,000
+11.0%
91,581
-0.7%
0.00%0.0%
Q2 2019$200,000
-19.4%
92,218
+0.7%
0.00%0.0%
Q1 2019$248,000
-45.4%
91,542
-3.1%
0.00%
-50.0%
Q4 2018$454,000
-49.7%
94,509
-0.8%
0.00%
-33.3%
Q3 2018$902,000
+11.1%
95,235
+14.1%
0.00%0.0%
Q2 2018$812,000
+20.8%
83,488
+30.8%
0.00%
+50.0%
Q1 2018$672,000
+55.9%
63,848
-5.1%
0.00%
+100.0%
Q4 2017$431,000
-0.2%
67,280
+19.2%
0.00%
-50.0%
Q3 2017$432,000
+16.4%
56,431
+8.1%
0.00%
+100.0%
Q2 2017$371,000
+84.6%
52,212
+0.7%
0.00%0.0%
Q1 2017$201,000
+103.0%
51,863
+7.1%
0.00%
Q4 2016$99,000
-99.9%
48,445
-0.3%
0.00%
-100.0%
Q3 2016$130,168,000
-12.9%
48,570
+0.2%
0.00%0.0%
Q2 2016$149,368,000
-66.6%
48,496
-7.5%
0.00%
-50.0%
Q1 2016$447,000,000
-40.7%
52,418
-5.6%
0.00%
-33.3%
Q4 2015$754,000,000
+142433.1%
55,549
+0.8%
0.00%
+50.0%
Q3 2015$529,000
-99.9%
55,090
-4.2%
0.00%
-33.3%
Q2 2015$827,281,000
+50.3%
57,530
-6.4%
0.00%
+50.0%
Q1 2015$550,273,000
+46.4%
61,483
-0.2%
0.00%0.0%
Q4 2014$375,961,000
-44.6%
61,633
-3.8%
0.00%
-33.3%
Q3 2014$678,480,000
-8.5%
64,068
+2.4%
0.00%0.0%
Q2 2014$741,336,000
-22.3%
62,560
-2.1%
0.00%
-25.0%
Q1 2014$954,116,000
+4.0%
63,906
+2.2%
0.00%0.0%
Q4 2013$917,257,000
-16.7%
62,526
-3.4%
0.00%
-33.3%
Q3 2013$1,101,160,000
+7.1%
64,698
+4.4%
0.01%0.0%
Q2 2013$1,027,983,00061,9640.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders